Icariin induces osteoblast differentiation and mineralization without dexamethasone in vitro

Planta Medica

Volumn 79, Issue 16, 2013, Pages 1501-1508

  Ma, Xiao Ni ^a   Zhou, Jian ^a   Ge, Bao Feng ^a   Zhen, Ping ^a   Ma, Hui Ping ^a   Shi, Wen Gui ^a   Cheng, Kui ^a   Xian, Cory J ^b   Chen, Ke Ming ^a  

^a LANZHOU GENERAL HOSPITAL   (China)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

dexamethasone; differentiation; icariin; osteoblasts; proliferation

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; ICARIIN; MESSENGER RNA; OSTEOCALCIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE MATRIX; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MINERALIZATION; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DEXAMETHASONE; FLAVONOIDS; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84887433210     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1350802     Document Type: Article

References (48)

1. Yamaguchi M. Isoflavone and bone metabolism: its cellular mechanism and preventive role in bone loss. J Health Sci: 2002; 48 209 222 (Pubitemid 41295320)
2. Huang J., Yuan L., Wang X., Zhang T. L., Wang K. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci: 2007; 81 832 840 (Pubitemid 47337100)
3. Ma H. P., Ming L. G., Ge B. F., Zhai Y. K., Song P., Xian C. J., Chen K. M. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem: 2011; 112 916 923
4. Mok S. K., Chen W. F., Lai W. P., Leung P. C., Wang X. L., Yao X. S., Wong M. S. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol: 2010; 159 939 949
5. Bao J. R., Yang J. W., Li S. F., Zhao W., Zhang Q., Yan Y. [Effects of icariin on ovariectomized osteoporotic rats]. Wei Sheng Yan Jiu: 2005; 34 191 193
6. Chen K. M., Ge B. F., Liu X. Y., Ma P. H., Lu M. B., Bai M. H., Wang Y. Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie: 2007; 62 388 391 (Pubitemid 46847945)
7. Ming L. G., Chen K. M., Xian C. J. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol: 2013; 228 513 521
8. Jorgensen N. R., Henriksen Z., Sorensen O. H., Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids: 2004; 69 219 226 (Pubitemid 38748717)
9. Alm J. J., Heino T. J., Hentunen T. A., Vaananen H. K., Aro H. T. Transient 100 nM dexamethasone treatment reduces inter- and intraindividual variations in osteoblastic differentiation of bone marrow-derived human mesenchymal stem cells. Tissue Eng Part C Methods: 2012; 18 658 666
10. Canalis E. Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep: 2005; 3 98 102
11. Cox R. F., Jenkinson A., Pohl K., OÊBrien F. J., Morgan M. P. Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment. PloS One: 2012; 7 e41679
12. Hintze V., Miron A., Moller S., Schnabelrauch M., Heinemann S., Worch H., Scharnweber D. Artificial extracellular matrices of collagen and sulphated hyaluronan enhance the differentiation of human mesenchymal stem cells in the presence of dexamethasone. J Tissue Eng Regen Med: 2012; 10.1002/term.1528
13. Luppen C. A., Smith E., Spevak L., Boskey A. L., Frenkel B. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3 T3-E1 osteoblast cultures. J Bone Miner Res: 2003; 18 1186 1197 (Pubitemid 37294911)
14. Ventura A., Brunetti G., Colucci S., Oranger A., Ladisa F., Cavallo L., Grano M., Faienza M. F. Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency. Biomed Res Int: 2013; 2013 1 8
15. He Q., Huang H. Y., Zhang Y. Y., Li X., Qian S. W., Tang Q. Q. TAZ is downregulated by dexamethasone during the differentiation of 3 T3-L1 preadipocytes. Biochem Biophys Res Commun: 2012; 419 573 577
16. Jaiswal R. K., Jaiswal N., Bruder S. P., Mbalaviele G., Marshak D. R., Pittenger M. F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem: 2000; 275 9645 9652 (Pubitemid 30185197)
17. Naito M., Omoteyama K., Mikami Y., Takahashi T., Takagi M. Inhibition of Wnt/beta-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26. Histochem Cell Biol: 2012; 138 833 845
18. Hardy R., Cooper M. S. Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells. Front Endocrinol: 2011; 2 1 8
19. Lian J. B., Shalhoub V., Aslam F., Frenkel B., Green J., Hamrah M., Stein G. S., Stein J. L. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3 T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology: 1997; 138 2117 2127 (Pubitemid 27180832)
20. Ducy P., Zhang R., Geoffroy V., Ridall A. L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell: 1997; 89 747 754 (Pubitemid 27516177)
21. Lo K. W., Kan H. M., Ashe K. M., Laurencin C. T. The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tissue Eng Regen Med: 2012; 6 40 48
22. Fratzl-Zelman N., Horandner H., Luegmayr E., Varga F., Ellinger A., Erlee M. P., Klaushofer K. Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3 T3-E1 cells. Bone: 1997; 20 225 236 (Pubitemid 27141834)
23. Barbara A., Delannoy P., Denis B. G., Marie P. J. Normal matrix mineralization induced by strontium ranelate in MC3 T3-E1 osteogenic cells. Metabolism: 2004; 53 532 537 (Pubitemid 38419200)
24. Chen K. M., Ge B. F., Ma H. P., Liu X. Y., Bai M. H., Wang Y. Icariin, a flavonoid from the herb Epimedium enhances the osteogenic differentiation of rat primary bone marrow stromal cells. Pharmazie: 2005; 60 939 942 (Pubitemid 41820762)
25. Zhu X. F., Zhang R. H., Sun S. M., Wang Y. C., Wang P. P., Yang L., Han L. Icariin inducing the differentiation of MC3 T3-E1 Subclone14 cells via estrogen receptor and p 38MAPK signaling pathway in vitro. Chin J Gerontol: 2012; 5 957 960
26. Chen T. L., Hauschka P. V., Cabrales S., Feldman D. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology: 1986; 118 250 259 (Pubitemid 16188143)
27. Hsieh T. P., Sheu S. Y., Sun J. S., Chen M. H., Liu M. H. Icariin isolated from Epimedium pubescens regulates osteoblasts anabolism through BMP-2, SMAD4, and Cbfa1 expression. Phytomedicine: 2010; 17 414 423
28. Zhao J., Ohba S., Shinkai M., Chung U. I., Nagamune T. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner. Biochem Biophys Res Commun: 2008; 369 444 448
29. Rauch A., Seitz S., Baschant U., Schilling A. F., Illing A., Stride B., Kirilov M., Mandic V., Takacz A., Schmidt-Ullrich R., Ostermay S., Schinke T., Spanbroek R., Zaiss M. M., Angel P. E., Lerner U. H., David J. P., Reichardt H. M., Amling M., Schutz G., Tuckermann J. P. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab: 2010; 11 517 531
30. Ming L. G., Lv X., Ma X. N., Ge B. F., Zhen P., Song P., Zhou J., Ma H. P., Xian C. J., Chen K. M. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. Endocrinology: 2013; 154 1202 1214
31. Ming L. G., Chen K. M., Xian C. J. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling. J Cell Physiol: 2013; 228 513 521
32. Kagami H., Agata H., Sumita Y., Tojo A. Heterogeneous responses of human bone marrow stromal cells (Multipotent mesenchymal stromal cells) to osteogenic induction. Stem cells and cancer stem cells, Vol. 2. Amsterdam Springer: 2012; 307 314
33. Chiang Z. C., Yu S. H., Chao A. C., Dong G. C. Preparation and characterization of dexamethasone-immobilized chitosan scaffold. J Biosci Bioeng: 2012; 113 654 660
34. Wang X., Schroder H. C., Diehl-Seifert B., Kropf K., Schlossmacher U., Wiens M., Muller W. E. Dual effect of inorganic polymeric phosphate/ polyphosphate on osteoblasts and osteoclasts in vitro. J Tissue Eng Regen Med: 2012; 10.1002/term.1465
35. Ma X., Zhang X., Jia Y., Zu S., Han S., Xiao D., Sun H., Wang Y. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells. Int Orthop: 2013; 37 1399 1404
36. Canalis E., Mazziotti G., Giustina A., Bilezikian J. P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int: 2007; 18 1319 1328 (Pubitemid 47389469)
37. Maniatopoulos C., Sodek J., Melcher A. H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res: 1988; 254 317 330
38. Anderson R. E., Kemp J. W., Jee W. S., Woodbury D. M. Effects of cortisol and fluoride on ion-transporting ATPase activities in cultured osteoblastlike cells. In Vitro: 1984; 20 847 855 (Pubitemid 15170039)
39. Chen T. L., Cone C. M., Feldman D. Glucocorticoid modulation of cell proliferation in cultured osteoblast-like bone cells: differences between rat and mouse. Endocrinology: 1983; 112 1739 1745 (Pubitemid 13049334)
40. Chung C. H., Golub E. E., Forbes E., Tokuoka T., Shapiro I. M. Mechanism of action of beta-glycerophosphate on bone cell mineralization. Calcif Tissue Int: 1992; 51 305 311
41. Jaiswal N., Haynesworth S. E., Caplan A. I., Bruder S. P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem: 1997; 64 295 312 (Pubitemid 27065443)
42. Schwarz R. I. Procollagen secretion meets the minimum requirements for the rate-controlling step in the ascorbate induction of procollagen synthesis. J Biol Chem: 1985; 260 3045 3049 (Pubitemid 15139342)
43. Graves S., Francis M., Gundle R., Beresford J. Primary culture of human trabecular bone: effects of L-ascorbate-2-phosphate. Bone: 1994; 15 132 133
44. Dai W., Dong J., Fang T., Uemura T. Stimulation of osteogenic activity in mesenchymal stem cells by FK506. J Biomed Mater Res A: 2008; 86 235 243 (Pubitemid 351799504)
45. Abe Y., Aida Y., Abe T., Hirofuji T., Anan H., Maeda K. Development of mineralized nodules in fetal rat mandibular osteogenic precursor cells: requirement for dexamethasone but not for beta-glycerophosphate. Calcif Tissue Int: 2000; 66 66 69
46. Zhou J., Ming L. G., Ge B. F., Wang J. Q., Zhu R. Q., Wei Z., Ma H. P., Xian C. J., Chen K. M. Effects of 50 Hz sinusoidal electromagnetic fields of different intensities on proliferation, differentiation and mineralization potentials of rat osteoblasts. Bone: 2011; 49 753 761
47. Joseph E. W., Pratilas C. A., Poulikakos P. I., Tadi M., Wang W., Taylor B. S., Halilovic E., Persaud Y., Xing F., Viale A., Tsai J., Chapman P. B., Bollag G., Solit D. B., Rosen N. The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner. Proc Natl Acad Sci USA: 2010; 107 14903 14908
48. Ma X. N., Liu X. Y., Yang Y. F., Xiao F. J., Li Q. F., Yan J., Zhang Q. W., Wang L. S., Li X. Y., Wang H. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism. Biochem Biophys Res Commun: 2011; 410 803 808